VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 4438 · 118th Congress

John W. Walsh Alpha-1 Home Infusion Act of 2023

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

MSR SalazarSponsor
59 cosponsors · 33 D, 26 R
GCD Connolly BHD Higgins WKD Keating CPD Pingree BPR Posey JPD Panetta PTD Tonko DWD Wasserman Schultz DDD Davis DRD Ross DBR Bacon BOR Owens ADR D'Esposito MDD Dean NLR Langworthy AED Espaillat TKR Kean BFR Fitzpatrick BPD Pascrell NLR LaLota DMD Matsui ABD Bera ASR Smith RRD Ruiz MSD Sherrill TCD Carter JCD Crow JVR Van Drew JGD Gottheimer MTD Thompson YCD Caraveo AKD Kim SPD Peters AAD Adams CSR Smith ACD Craig JLD Larson CMR Maloy JJD Jackson WND Nickel BFR Finstad NMR Malliotakis MLR Lawler BWR Williams DVR Valadao YKR Kim MRR Rogers GBR Bilirakis JGR González-Colón JMD Moskowitz VFD Foushee PMR McHenry AGR Garbarino DRR Rouzer JRR Rutherford RHR Hudson TKD Kennedy JGD Garamendi DPD Phillips

8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency.

What it does: CRS summary · Introduced in House · Jun 30, 2023

John W. Walsh Alpha-1 Home Infusion Act of 2023

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: John W. Walsh Alpha-1 Home Infusion Act of 2023

Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Jun 30, 2023

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.